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Objectives. This study was performed to develop a method for 
identifying patients at increased risk for morbidity or mortality 
after coronary artery bypass graft surgery. 
Background. Postoperative morbidity is more common than 
mortality and is important because of its relation to cost. 
Methods. Univariate and forward stepwise logistic regression 
analysis was used to retrospectively analyze a group of 1,567 
consecutive patients who underwent bypass urgery between July 
1991 and December 1992. We developed a model that predicted 
postoperative morbidity or mortality, or both, which was then 
prospectively validated in a group of 1,235 consecutive patients 
operated on between January 1993 and April 1994. A clinical risk 
score was derived from the model to simplify utilization of the 
data. 
Results. The following factors, listed in decreasing order of 
significance, were found to be significant independent predictors: 
cardiogenic shock, emergency operation, catheterization-induced 
coronary artery closure, severe left ventricular dysfunction, in- 
creasing age, cardiomegaly, peripheral vascular disease, chronic 
renal insufficiency, diabetes mellitus, low body mass index, female 
gender, reoperation, anemia, cerebrovascular disease, chronic 
obstructive pulmonary disease, renal dysfunction, low albumin, 
elevated blood urea nitrogen, congestive heart failure and atrial 
arrhythmias. Observed morbidity and mortality for the validation 
group fell within the 95% confidence interval of that predicted by 
the model. Costs were closely related to the incidence of postop- 
erative morbidity. 
Conclusions. Analysis of preoperative patient variables can 
predict patients at increased risk for morbidity or mortality, or 
both, after bypass urgery. Increased morbidity results in higher 
costs. Different strategies for high and low risk patients hould be 
used in cost reduction efforts. 
(J Am Coil Cardiol 1996;28:1147-53) 
Coronary artery bypass graft surgery (CABG) is now the most 
commonly performed major operation in the United States 
(1). Operative mortality, has been the primary criterion for 
judging the quality of surgical results, and several models have 
been developed to predict mortality based on preoperative 
data (2-5). However, death after CABG is an uncommon 
event, with an incidence <4% (6). The ability to predict 
operative mortality is important o patients, families and 
physicians, but it is an incomplete method for determining 
surgical outcome. Major morbidity is more common than 
mortality after CABG and has greater economic importance 
because it results in a prolonged hospital stay and greater 
utilization of resources. A few statistical models that predict 
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morbidity or cost, or both, have been developed, but the results 
have not been extensively verified or proven clinically useful 
(7-13). This study presents a clinical risk score (CRS) based 
entirely on preoperative data and that reliably predicts mor- 
bidity and mortality for patients undergoing CABG. 
Methods 
This study was derived from the Allegheny General Hospi- 
tal's cardiothoracic surgery data base. The data base was 
implemented in July 1991, with prospective data collection on 
all patients undergoing cardiac surgery. This computerized 
system now contains detailed ata on >6,000 patients. Daily 
prospective data collection is performed by research staff, and 
the validity of the entered ata is checked by reabstracting 15% 
of the patient entries and by randomly reentering 10% of the 
patient records. This data base contains 170 preoperative 
variables pertaining to the severity of the patient's primary 
condition and comorbid diseases before the operation. An- 
other 50 variables document procedural and intraoperative 
events, and another 100 variables are specific for postoperative 
outcome and discharge status. Standardized criteria and deft- 
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Abbreviations and Acronyms 
CABG coronary, artery, bypass graft surgery 
CRS = clinical risk score 
ROC - receiver operating characteristic 
nitions for variables are listed in Appendix 1. Data are 
retrieved from the data base by a procedural query language, 
and computations are performed using SPSS, BMDP and EPI 
INFO statistical programs. 
Hospital charge data were obtained from a computerized 
system that records all resources consumed and services pro- 
vided during a patient's hospital stay. Total hospital charges 
are imperfect reflections of actual cost, but are often used as a 
proxy for cost (14). Because charges do not precisely reflect 
actual costs, we chose to compare the relative charges for 
various groups of patients rather than analyzing actual costs in 
absolute amounts. In this scheme, the cost for the least 
expensive group was given a value of one, and the costs for the 
more expensive groups were expressed as multiples of the low 
cost group. 
Study design. All patients who had CABG only during the 
study period were analyzed and those who had concomitant 
procedures were excluded. Data were prospectively collected 
on 1,567 consecutive CABG patients between July 1, 1991 and 
December 31, 1992. Univariate and forward stepwise multivar- 
iate logistic regression analysis was then performed retrospec- 
tively on these 1,567 patients (test group) to develop a model 
to predict morbidity and mortality. The clinical predictive 
model was validated on 1235 consecutive patients undergoing 
CABG between January 1, 1993 and April 30, 1994. Table 1 
lists the clinical and demographic information for the test and 
validation groups. No significant differences were noted be- 
tween the two study groups. 
Statistical analysis. The association of 125 preoperative 
variables with postoperative morbidity or mortality was deter- 
mined by univariate analysis. For the purpose of analysis, 
morbidiF was defined as an unexpected postoperative compli- 
cation, major or minor, which resulted in the increased con- 
sumption of hospital resources owing to the required treat- 
ment. The definitions of major and minor complications are 
given in Appendix 2. Mortality was defined as death at any time 
during the hospital stay. Morbidity and mortality were handled 
as separate nd points. Categoric variables were tested for 
Table 1. Study Groups 
Tcst Group Validation Group 
(n 1567) (n = 1,235) 
Mean (+SD) age (yr) 65 ± 9 65 ± 10 
Male/female (%) 70/3(/ 72/28 
Emergency or urgent operation (%) 16 13 
Reoperation (CABG) (%) 9 8 
CABG - coronary artery bypass graft surge~'. 
association with morbidity and mortality using the chi-square 
test or the Fisher exact test, as appropriate. Dichotomous 
variables were converted to numerical values--0 = absent and 
1 = present. If dichotomous variables could not be verified, 
they were considered to be missing. In the univariate contin- 
gency tables, relative risk was used to assess the association 
between the independent variable and the end point. Contin- 
uous data were assessed for association with the end points 
using the Student t test and one-way analysis of variance. With 
the exception of age, left ventricular function and creatinine, 
continuous data were reduced to dichotomous variables by 
identification of thresholds. The data were ranked from high- 
est to lowest, and the observed end point rates were computed 
for each data increment. Intervals with similar rates of end 
point incidence were combined, and the interval with the best 
end point association was selected as the cutoff point. For 
regression analysis, indicator variables were created for age, 
left ventricular ejection fraction and serum creatinine. If >5% 
of any variable was missing, the variable was excluded from the 
analysis. Missing variable patterns were tested for evidence of 
nonrandomization by subdividing the data into two subgroups 
and testing the distribution of the other variables in the 
analysis between the two groups. Variables that reflected 
treatment processes or practice preferences instead of disease 
diagnosis were excluded from consideration as independent 
variables. Variables were tested for significant interactions by 
univariate analysis of variable distribution i subgroups and by 
analysis of the correlation matrix and the computation of 
variable tolerance values. Multivariate correlates of morbidity 
or mortality were determined by stepwise forward regression 
analysis using the computer program BMDP-LR. The 
Hosmcr-Lemeshow statistic was used to evaluate the goodness 
of fit of the regression modules, and the predictive accuracy of 
the models was tested by computing the area under the 
receiver operating characteristic (ROC) curve. 
Development of the risk prediction model, To create a 
calibrated clinical risk prediction model that could accurately 
predict risk for an individual patient according to his or her 
specific haracteristics, univariate variables with p < 0.15 were 
entered into two separate forward stepwise logistic regression 
modules. Module 1 comprised those variables relevant to 
operative morbidity and module 2 comprised variables associ- 
ated with operative mortality. Mortality was censored in mod- 
ule 1. Statistically significant independent variables (p < 0.05) 
from modules 1and 2 were entered into a final model in which 
operative morbidity and mortality were combined as one 
dependent variable. The goodness of fit for all three models 
was verified using the Hosmer-Lemeshow chi-square test. To 
assess the ability of the independent variables to predict he 
end point, their odds ratio, which is related to the coefficient in 
stepwise logistic regression analysis, was calculated--the odds 
ratio being the ratio of the odds of achieving an end point in a 
group, divided by the odds of achieving the end point in the 
reference group. 
Clinical risk score. A CRS was developed from the logistic 
regression analysis to simplify utilization of the data. Signifi- 
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Table 2. Risk Factors for Morbidity and Mortality 
Clinical Incidence 
Variable Risk Score Odds Ratio Coefficient (%) 
Cardiugenic shock 7 29.9 5.311 2 
Emergency operation 5 7.14 2.76 5 
Urgent operation 4 3.5 1.945 8 
Catheterization-induced coronary, closure 4 3.68 1.874 3 
Severe left ventricular dysfunction (ejection 4 2.89 1.906 7 
fraction <30%) 
Age ->75 yr 3 2.93 1.845 16 
Cardiomegaly 2 3.3 2.4 7 
Peripheral vascular disease 2 1.7 2.177 17 
Chronic renal insufficiency (creatinine 2 2.6 1.613 5 
>1.9 mgjdl) 
Age 70-74 yr 2 1.45 1.14 19 
Insulin-dependent diabetes mellitus 2 2.5 1.121 9 
Non-insulin-dependent iabetes mellitus 1 1.49 0.3384 14 
Low body mass index 1 1.45 0.3158 23 
Female gender 1 1.48 0.3777 30 
Reoperation 1 1.39 0.2115 9 
Age 65-69 yr 1 1.35 0.3024 21 
Anemia 1 1.8 0.332i 15 
Cerebrovascular disease 1 1.62 0.5855 7 
Chronic obstructive pulmonary, disease 1 1.39 0.7076 15 
Albumin <4.0 mgjdl 1 1.23 0.21113 48 
Renal dysfunction (creatinine 1.5-1.9 mg/dl) 1 1.8 0.8435 5 
Elevated blood urea nitrogen (>29 mg/dl) 1 1.74 0.5522 8 
Congestive h art failure 1 2.3 0.8262 11 
Atrial arrhythrnia 1 1.4 0.5812 7 
cant independent predictors of morbidity and mortality from 
the logistic regression model were assigned points to reflect 
their predictive power. The points for the scoring system were 
derived from the variables' logistic regression coefficient, odds 
ratio and relative risk. The risk points were assigned to the 
predictive factors by taking the average of the coefficients for 
each variable from the modules and then adding increments of 
points based on the variables' average odds ratio, relative risk 
and improvement in the area under the ROC curve. Variables 
with coefficients <1 were assigned one point and were not 
eligible for additive weight. The predictive power of the CRS 
was evaluated by scoring the risk of morbidity or mortality for 
each patient in the test and validation groups. The patients 
were then stratified according to their predicted risk from 
lowest to highest. The predicted and observed rates for each 
interval were compared using contingency tables. Patients with 
similar risk scores were combined to create calibrated risk 
intervals. The relation between the CRS and end point rates 
was compared using linear regression. Ninety-five percent 
confidence intervals were calculated for the predicted results 
to see if the validation observed rates fell within those limits. 
Receiver operating characteristic curves were used to verify 
the predictive accuracy of the CRS in the validation group. 
Resu l ts  
Risk prediction model. Forward stepwise logistic regres- 
sion analysis identified 20 independent predictors of morbidity 
or mortality, or both. The risk factors, beta coefficients, odds 
ratios and weighted scores are listed in Table 2. The most 
powerful predictors were those associated with emergency 
operation and depressed cardiac function. Other factors reflect 
comorbid disease processes, such as chronic obstructive pup 
monary disease, renal insufficiency, peripheral vascular dis- 
ease, diabetes, low serum albumin and anemia. Finally, age, 
gender and low body mass were also significant predictors. 
Obesity was not a predictor of morbidity or mortality. 
The scoring is shown in Table 2. The total number of points 
is 50, but the maximal score for a patient is 37 because some 
factors such as age, serum creatinine and surgical priority are 
listed more than one time depending on severity, but can only 
be scored once per patient. It is rare for a patient's core to 
exceed 20. Predicted operative mortality was divided into five 
categories of increasing risk, and predicted morbidity was 
divided into four categories by increasing incidence, as defined 
by a patient's total CRS. These categories are presented in 
Table 3. 
Validation of the risk prediction model. The operative 
mortality rate in the test group was 3.8% (59 of 1,567). Major 
and minor morbidity occurred in 16% and 36% of the patients, 
respectively, whereas 48% of the patients had no major or 
minor postoperative morbidity. The results in the validation 
group were very similar. Operative mortality was 3%, the 
major morbidity rate was 12% and the incidence of minor 
morbidity was 40%. Forty-eight percent of the patients in the 
validation group had no morbidity. 
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Table 3. Coronary Artery Bypass Graft Surgery Risk Groups 
Points % Predicted 
Mortality 
Low 0 4 0.2 
Average 5-8 2 
Moderate 9-11 6 
High 12-18 30 
Extremely high It)+ 95 
Morbidity 
Low (}-2 20 
Moderate 3-5 50 
High 6-8 74 
Extremely high 9+ 93 
100 
8O 
"[~ 60 
0 
40 
20 
0 / 
Low Average Moderate High Extremely High 
0-4 5-8 9-11 12-18 19+ 
Risk Group 
Figure 2. Bar graph showing the predicted and observed incidence of
mortality by increasing risk category. Symbols as in Figure 1. 
The predicted versus observed morbidity and mortality by 
CRS category for the validation group are shown in Figures 1 
and 2, respectively, The observed morbidity and mortality fell 
within the 95% confidence interval of the predicted rate for 
each category. The correlation coelticient between the CRS 
and the incidence of morbidity was 0.98, and that between the 
CRS and death was 0.97. The area under the ROC curve was 
analyzed to determine the capacity of the model to correctly 
measure the occurrence of predicted morbidity and mortality. 
The predictive power for morbidity was 0.82, and for mortality 
it was 0.86. 
Morbidity groups and cost. To examine the relation be- 
tween cost and morbidity, the patients were divided into three 
groups based on the incidence and severity of postoperative 
complications. Group 1 had no complications; group 2 had one 
or more minor complications but no major complications; and 
group 3 had one or more major complications with or without 
minor complications or death, or both. Group 1 was the low 
cost group and was assigned a relative cost of one. Costs for 
group 2 were 1.7 times higher than costs for group 1. Costs for 
group 3 were 3.4 times higher than costs for group 1. In terms 
of overall costs, group 1 constituted 48% of the patients but 
only 32~ of the total costs, whereas group 3 constituted only 
12% of the patients but accounted for 27% of the total costs 
(Fig. 3). 
Figure I. Bar graph showing the predicted (solid bars) and observed 
(hatched bars) incidence ofmorbidity by increasing risk categow. Ext. : 
extrcmely. 
100 
8O 
"¢D 
60 
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4o 
2O 
Low Moderate High Ext. High 
0-2 3-5 6-8 9+ 
Risk Group 
Discuss ion  
Published reports. The capacity to predict he outcome of 
CABG before undertaking the operation has always been of 
interest to physicians and their patients. Recently, this subject 
has become of greater general interest because CABG ac- 
counts for a significant portion of the total health care expen- 
diture in the United States. However, it is ditficult o compare 
the results of one surgeon or institution with those of another 
because the acuity of patient illness and the incidence of 
comorbid diseases are not necessarily equal. A validated 
scoring system based on readily available preoperative infor- 
mation that correlates with morbidity and mortality provides a 
framework for developing meaningful outcome analysis in 
CABG. 
Several recent reports have addressed the issue of predict- 
ing outcome in CABG using multivariate regression analysis. 
Parsonnet et al. (2) published a prospectively validated CRS 
system based on readily available patient data. The analysis 
included all types of cardiac surgery, including CABG, valve 
replacements, combined CABG and valve replacement and 
other less common procedures. In addition, the study modeled 
operative mortality but not morbidity. Subsequent studies by 
several investigators have analyzed factors that predict in- 
creased length of hospital stay, major complications and 
morbidity (7-13). Other reports have combined ata from 
multiple institutions to predict mortality (3,4,13). Higgins et al. 
(5) published aCRS system that predicted both morbidity and 
mortality in patients undergoing CABG or CABG with con- 
Figure 3. Pie graphs illustrating (left) number of patients in each 
morbidity group and (right) percentage of total costs generated by 
each morbidity group. 1 no morbidity; 2 = minor morbidity; 3 = 
major morbidity. 
1 
1 48% 32% 
40% 27% 
JACC Vol. 28. No. 5 MAGOVERN ET AL. 1151 
November 1, 1996:1147-53 PREDICTING MORBIDITY AFTER CORONARY BYPASS 
comitant procedures, but a discussion of cost was not included. 
This study builds on the body of earlier work but differs in that 
we have focused primarily on morbidity. In addition, this study 
examined only patients having isolated CABG, whereas several 
previous tudies looked at all patients having cardiac surgery or 
included patients having concomitant procedures in addition 
to CABG. 
In the past 5 years, the states of New York and Pennsylva- 
nia have published reports on operative mortality for CABG by 
institution and by surgeon (15,16). The reports have attempted 
to stratify patients by expected risk, but the risk analysis is not 
as detailed as the one presented in this paper or in the 
publication by Higgins et al. (5). The assumption common to 
these efforts is that patient outcome is predominantly a 
function of surgical skill and institutional care. Some data exist 
to support his assumption. O'Connor et al. (3) reported that 
differences in operative mortality between different centers 
and surgeons could not be accounted for solely by differences 
in case mix. Other reports have demonstrated lower operative 
mortality for surgeons and institutions having a higher volume 
of operations (17). This finding is confirmed by the data from 
Pennsylvania: Allegheny General Hospital has had the highest 
volume of CABG procedures in the state for several years and 
has had lower than expected mortality in each of the years that 
the data have been published (16). However, surgeon-specific 
factors are not the major determinants of patient outcome. A
recent analysis of "report cards on cardiac surgeons" found 
that combined surgeon-specific and institution-specific actors 
explained <10% of the variance in observed mortality (18). 
This report emphasizes the importance of patient-related 
factors in determining postoperative outcome. We have iden- 
tified multiple factors that are associated with increased mor- 
bidity, which are consistent with previously identified risk 
factors. In general, the predictors of an adverse outcome can 
be divided into several categories: 1) unstable patient condi- 
tion leading to an urgent or emergency operation for cardio- 
genie shock, failed angioplasty, unstable angina or acute 
myocardial infarction; 2) impaired cardiac function as evi- 
denced by cardiogenic shock, low ejection fraction, congestive 
heart failure or cardiomegaly; 3)comorbid iseases, especially 
peripheral vascular disease, cerebrovascular disease, diabetes, 
renal insufficiency and chronic obstructive pulmonary disease; 
4) physical factors, such as advanced age, female gender and 
small stature; and 5) nonspecific laboratory abnormalities, such 
as anemia, low albumin and elevated creatinine. Categories of 
risk factors associated with the largest increase in morbidity 
and mortality are emergency operation and impaired cardiac 
function. 
Clinical significance. This analysis has practical signifi- 
cance for improvements in clinical practice. To date, most 
efforts in this area have focused on reducing costs by decreas- 
ing length of hospital stay. This strategy will be the most 
effective in patients who have low or average risk for morbidity. 
Early extubation, short intensive care stay and early discharge 
can be reliably accomplished in these patients and tracked by 
means of critical pathways. In contrast, patients who suffer 
major complications uch as stroke or respiratory failure 
cannot be "fast-tracked" for early discharge. This model 
identifies these high risk patients prospectively with an accu- 
racy of -82%. 
A logical question is whether anything can be done to 
reduce complications in high risk patients. Patients with poor 
ventricular function and unstable symptoms are at high risk but 
also derive the largest benefit from the operation (19). Some 
patients who are at high risk because of comorbid iseases and 
conditions may be better served with medical therapy or 
catheter-based interventions, but the majority of high risk 
patients will need to have an operation. In this situation the 
challenge becomes how to reduce or prevent complications, 
which can be facilitated by identifying the patients at high risk 
before surgery. This allows the development of protocols to 
reduce specific omplications in selected patients, without he 
necessity of changing the approach to all patients, many of 
whom are not at risk for the specific problem. For example, a
recent study has shown a large reduction in postoperative 
stroke rates in high risk patients by maintaining a high blood 
pressure during cardiopulmonary bypass (20). Protocols could 
also be developed to manage elderly patients undergoing 
CABG, especially those who present with depressed left 
ventricular function and unstable angina. 
Study limitations. The major limitation of this study is in 
the area of cost analysis. Reliable data on the actual cost for 
each patient are difficult o determine. Hospital charges have 
therefore been used as a surrogate for cost, which has been 
done in most studies on this subject. Another problem is that 
hospital charges for CABG vary widely by region and individ- 
ual hospital, which makes analysis of charges at one institution 
difficult o generalize to other institutions. In addition, hospital 
charges for CABG are decreasing rapidly, which makes retro- 
spective data obsolete within a year or two. To avoid these 
methodologic problems, we have chosen to greatly simplify the 
issue by making an analysis of relative cost for low, medium 
and high cost groups, which uses the low cost group as a 
benchmark. This is a superficial approach to cost analysis, but 
this is all that is warranted given the limitations of the data. 
This model identifies patients at high risk for postoperative 
morbidity and mortality but does not directly predict cost. 
Nonetheless, we have demonstrated that hospital charges are 
closely related to the occurrence and severity of postoperative 
complications, which means that the model will prospectively 
identify patients who are at risk for morbidity and excess cost. 
The model was developed from the experience of one institu- 
tion. It has been validated at the Allegheny General Hospital, 
but not at other institutions. This will need to be done before 
the model can be used to compare the results between different 
cardiac surgery centers. 
Conclusions. This study presents a model that prospec- 
tively predicts postoperative morbidity and mortality using 
data that are readily available to the clinician before surgery. 
Patients who develop minor and major complications after the 
operation have excess cost in comparison to patients who have 
no complications. Cost reduction i  clinical practice should use 
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different strategies for patients depending on the risk level. 
The potential for cost reduction is greatest in high risk 
patients, but this requires a reduction of postoperative mor- 
bidity. 
Appendix 1 
Standardized Criteria and Definitions of  Variables 
Cardiogenic shock: Systolic blood pressure <90 mm Hg or 
mean systemic blood pressure <50 mm Hg and a cardiac 
index <2.0 liters/rain per m 2 and evidence of peripheral 
hypoperfusion 
Emergency operation: Operation performed immediately to 
prevent death. The patient is having an acute event that 
is refractory to all other appropriate forms of therapy 
and is hemodynamically unstable. 
Urgent operation: Operation performed to reverse or stabi- 
lize a deteriorating clinical condition. These patients are 
already receiving support with an intraaortic balloon 
pump, inotropic medications, nitroglycerin or heparin, 
or a combination of these. These operations are done 24 
to 48 b from the onset of the acute event precipitating 
the symptoms. 
Catheterization-induced coronary occlusion: latrogenic oro- 
nary occlusion or dissection secondary to a diagnostic 
catheterization or angioplasty, or both, that requires 
heart surgery within 24 h 
Severe left ventricular dysfunction: Left ventricular ejection 
fraction <30% 
Cardiomegaly: Enlarged heart as determined by chest radi- 
ography or ecbocardiography 
Peripheral vascular disease: Claudication, ischemic rest pain, 
prior peripheral vascular surgery, absent lower extremity 
pulses, inability to insert an intraaortic balloon pump 
from the groin and/or a noninvasive vascular test show- 
ing >50% obstruction of the lower extremity vasculature 
Chronic renal insufficiency: History of chronic renal disease 
or serum creatinine ->1.9 mg/dl, or both 
lnsu#n-dependent diabetes mellitus: Diabetes that has been 
treated with insulin before the surgical procedure 
Non-insulin-dependent diabetes: Diabetes that has been 
treated with oral hypoglycemic agents before the surgi- 
cal procedure 
Low body mass index." -<24 kg/m 2 
Reoperation: Any prior cardiac surgery 
Anemia: Hemoglobin -<12.5 g/dl and -<11 g/dl for males and 
females, respectively, or the need for preoperative blood 
transfusion 
Cerebrovascular disease: History of a transient ischemic 
attack, embolic stroke or nonembolic stroke and/or 
angiographic evidence of internal carotid stenosis >50% 
Chronic obstructive pulmonary disease: Pulmonary disease 
that results in functional disability or requires broncho- 
dilator therapy and/or esults in abnormal spirometry, as 
defined by a forced expiratory volume in 1 s, <75% of 
that pre. dieted 
Low serum albumin: <4.0 mg/dl 
Renal dysfunction: Serum creatinine 1.5 to 1.9 mg/dl 
Elevated blood urea nitrogen: Blood urea nitrogen 
>29 mg/dl 
Congestive heart failure: Documented history of or treat- 
ment for heart failure and/or clinical evidence of heart 
failure, as defined by an $3 gallop, jugular venous 
distention, pleural effusion, pulmonary edema, periph- 
eral edema or radiographic evidence of interstitial 
edema (flash pulmonary edema excluded) 
Atrial arrhythmias: Prior admission or outpatient treatment 
for atrial fibrillation, flutter or tachycardia 
Appendix 2 
Definitions of  Major and Minor Complications 
Major Complications 
Cardiovascular failure: Intraoperative or postoperative 
acute myocardial infarction, intraaortic balloon pump, 
ventricular assist device, arrest with resuscitation and/or 
inotropic cardiac support requiring two or more drugs 
for >24 h 
Respiratory failure: Postoperative ventilatory support for 
>48 h or tracheostomy, or both 
Acute renal failure: New onset of oliguria or increasing 
serum creatinine resulting in dialysis or worsening of 
prior renal insufficiency requiring initiation of dialysis 
Permanent cerebral deficit." Focal brain injury documented 
by scan with a permanent functional deficit 
Major wound infection: Any surgical wound site manifesting 
clinical evidence of sepsis requiring additional hospital 
stay or surgical treatment, or both, for resolution 
Pulmonary embolus: Documented by V/Q scan 
Surgical intervention after coronary artery, bypass grafting: Any 
surgical procedure performed uring the postoperative 
period necessary to treat an adverse vent that occurs 
secondary to bypass urgery 
Minor Complications 
Temporary central nervous ystem deficit." Documentation of
a focal event by scan without a permanent deficit 
Acute renal insuficiency: Oliguria or increasing serum cre- 
atinine requiring treatment with renal dose dopamine, 
diuretics or other pharmacologic means, but not result- 
ing in dialysis 
Atrial arrhythmias: Atrial fibrillation, flutter or tachycardia 
that is sustained long enough to be documented, pro- 
duces patient symptoms and requires treatment with 
pacing, electrical cardioversion or drugs 
Ventricular arrhythmias: Sustained ventricular fibrillation, 
tachycardia or premature contractions that require 
treatment with drugs, defibrillation, pacing and/or esult 
in consultation with an electrophysiologist 
Heart block." Complete heart block that is sustained, causes 
symptoms and requires treatment with drugs or pacing, 
or both 
Superficial wound infection: A wound site with clinical 
evidence of infection, but that only requires treatment 
with antibiotics and topical medications 
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Respirato~ insufficiency: Postextubat ion  oxygen desatura-  
tion, hypercapn ia  or labored respirat ions,  or all of  these, 
leading to pro longed oxygen therapy 
Pleural effusion: An effusion that  requires  thoracentes is  or 
o ther  therapy for reso lut ion 
Pneumothorax: A pneumothorax  that  requires  p lacement  of 
chest tube for reso lut ion 
Systemic sepsis: Cul ture -proven  respiratory,  ur inary  or 
b lood infect ion that  requires  addi t ional  drug therapy 
and causes a delay in d ischarge 
Gastrointestinal bleeding: Gast ro in test ina l  hemorrhage  doc- 
umented  by posit ive heme-stoo l  tests 
Postoperative mediastinal bleeding: Postoperat ive  chest tube 
dra inage of > 1,500 ml or reexplorat ion for b leeding,  or 
both  
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